VALUE CHAIN INSIGHTS

VALUE CHAIN INSIGHTS

  • Posted in: Value Chain Insights

    This year thus far has seen several high-profile deals and expansion moves in the contract development and manufacturing ...

  • Posted in: Value Chain Insights

    Biomanufacturing is a leading area of investment for the pharmaceutical majors. So what are the leading projects announced, ...

  • Posted in: Value Chain Insights

    Kåre Schultz, now president and CEO of H. Lundbeck A/S, has been appointed president and CEO of Teva Pharmaceutical Industries. ...

  • Posted in: Value Chain Insights

    The oncology sector is the largest therapeutic sector in the pharmaceutical industry. So what is in store for the global ...

  • Posted in: Value Chain Insights

    Batch processing is the historical and dominant form of manufacturing in the pharmaceutical industry, but continuous manufacturing ...

  • Posted in: Value Chain Insights

    Thermo Fisher Scientific has completed its $7.2-billion acquisition of Patheon. So what is the impact for Thermo, Patheon, ...

  • Posted in: Value Chain Insights

    Although the future of healthcare reform is unclear, debates on drug pricing continue. So what should be on the radar for ...

  • Posted in: Value Chain Insights

    Precision medicines, defined as a medical approach that proposes to prevent and treat disease based upon a person's unique ...

  • Posted in: Value Chain Insights

    Emma Walmsley, who became CEO of GlaxoSmithKline (GSK) on April 1, highlighted the priorities of the company following its ...

  • Posted in: Value Chain Insights

    Healthcare reform is taking center stage in US policy-making and debates. So what should be on the radar for the pharmaceutical ...

  • Posted in: Value Chain Insights

    The market for active pharmaceutical ingredients (APIs) is approximately $140 billion and is projected to reach nearly $190 ...

  • Posted in: Value Chain Insights

    A recent PwC report of more than 1,200 global executives and business leaders examined how top companies are meeting innovation ...

  • Posted in: Value Chain Insights

    Pharmaceutical industry leaders are calling for an orderly implementation relating to the regulation, manufacture, and supply ...

  • Posted in: Value Chain Insights

    The global biotechnology industry showed a slowdown in 2016. So what do the numbers show? A recent analysis by EY showed ...

  • Posted in: Value Chain Insights

    This year thus far has seen several high-profile deals in the pharmaceutical outsourcing market. So what moves should be ...